Simcoe Capital »

Cytek Biosciences shares owned by Simcoe Capital

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Simcoe Capital from 13F filings

Historical chart of Simcoe Capital investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Simcoe Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Simcoe Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 299k 5.05

More positions owned by Simcoe Capital

Homestreet (MCHB)
Great Lakes Dredge & Dock Corporation (GLDD)
Solaris Oilfield Infrstr (SEI)
Green Dot Corporation (GDOT)
Yatra Online Inc ord (YTRA)
Arhaus Incorporated Com Class A (ARHS)
Orion Marine (ORN)
Oportun Finl Corp (OPRT)
Uranium Royalty Corp (UROY)
Repro-Med Systems (KRMD)
Progyny (PGNY)
Helix Energy Solutions (HLX)
Innovex International (INVX)
Pubmatic Ord (PUBM)
Nordic American Tanker Shippin (NAT)

View all positions for Simcoe Capital

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Robeco Investment Management
State Street Corporation
Millennium Management
Geode Capital Management
Dimensional Fund Advisors
Wellington Management Company
Brown Capital Management
Goldman Sachs Group
Royce & Associates
Charles Schwab Investment Management
AQR Capital Management
Russell Investments

View all funds holding Cytek Biosciences